{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:27:33Z","timestamp":1792189653885,"version":"4.4.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.cll.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T09:19:13Z","timestamp":1490174353000},"page":"285-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Rift Valley Fever"],"prefix":"10.1016","volume":"37","author":[{"given":"Amy","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2017.01.004_bib1","unstructured":"World Organization for Animal Health (OIE). OIE-Listed diseases, infections and infestations in force in 2016. Available at: http:\/\/www.oie.int\/en\/animal-health-in-the-world\/oie-listed-diseases-2016\/. Accessed August 24, 2016."},{"key":"10.1016\/j.cll.2017.01.004_bib2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle, and man from east Africa","volume":"34","author":"Daubney","year":"1931","journal-title":"J\u00a0Pathol Bacteriol"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","article-title":"Present and future arboviral threats","volume":"85","author":"Weaver","year":"2009","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.cll.2017.01.004_bib4","doi-asserted-by":"crossref","first-page":"19506","DOI":"10.2807\/ese.15.10.19506-en","article-title":"Rift Valley fever\u2013a threat for Europe?","volume":"15","author":"Chevalier","year":"2010","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.cll.2017.01.004_bib5","first-page":"e1","article-title":"Potential effects of Rift Valley fever in the United States","volume":"17","author":"Hartley","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4081\/gh.2012.134","article-title":"A\u00a0temperature-limited assessment of the risk of Rift Valley fever transmission and establishment in the continental United States of America","volume":"6","author":"Konrad","year":"2012","journal-title":"Geospat Health"},{"key":"10.1016\/j.cll.2017.01.004_bib7","first-page":"13241","article-title":"7 CFR Part 331 and 9 CFR Part 121. Agricultural Bioterrorism Protection Act of 2002; possession, use, and transfer of biological agents and toxins; final rule","volume":"70","author":"US Department of Agriculture","year":"2005","journal-title":"Fed Reg"},{"issue":"52","key":"10.1016\/j.cll.2017.01.004_bib8","first-page":"13294","article-title":"42 CFR parts 72, 73 and 42 CFR part 1003. Posession, use, and transfer of Select agents and toxins; final rule","volume":"70","author":"US Department of Health and Human Services","year":"2005","journal-title":"Fed Reg"},{"key":"10.1016\/j.cll.2017.01.004_bib9","series-title":"Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens","author":"Workshop on Prioritization of Pathogens","year":"2015"},{"issue":"6268","key":"10.1016\/j.cll.2017.01.004_bib10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1126\/science.351.6268.16","article-title":"Unfilled Vials: scientifically feasible vaccines against major diseases are stalled for lack of funds","volume":"351","author":"Cohen","year":"2016","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cll.2017.01.004_bib11","doi-asserted-by":"publisher","first-page":"e1002030","DOI":"10.1371\/journal.ppat.1002030","article-title":"The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes","volume":"7","author":"Ferron","year":"2011","journal-title":"PLoS Pathog"},{"issue":"18","key":"10.1016\/j.cll.2017.01.004_bib12","doi-asserted-by":"publisher","first-page":"11974","DOI":"10.1128\/JVI.79.18.11974-11980.2005","article-title":"The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization","volume":"79","author":"Le May","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.cll.2017.01.004_bib13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0042-6822(87)90174-7","article-title":"Immunoelectron microscopy of Rift Valley fever viral morphogenesis in primary rat hepatocytes","volume":"161","author":"Anderson","year":"1987","journal-title":"Virology"},{"issue":"22","key":"10.1016\/j.cll.2017.01.004_bib14","doi-asserted-by":"publisher","first-page":"11152","DOI":"10.1128\/JVI.01519-08","article-title":"Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007","volume":"82","author":"Bird","year":"2008","journal-title":"J\u00a0Virol"},{"issue":"6","key":"10.1016\/j.cll.2017.01.004_bib15","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1128\/JVI.02095-06","article-title":"Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry","volume":"81","author":"Bird","year":"2007","journal-title":"J\u00a0Virol"},{"issue":"10","key":"10.1016\/j.cll.2017.01.004_bib16","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1128\/JVI.73.10.8196-8200.1999","article-title":"Genetic reassortment of Rift Valley fever virus in nature","volume":"73","author":"Sall","year":"1999","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cll.2017.01.004_bib17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-ento-010715-023819","article-title":"Rift Valley fever: an emerging mosquito-borne disease","volume":"61","author":"Linthicum","year":"2016","journal-title":"Annu Rev Entomol"},{"key":"10.1016\/j.cll.2017.01.004_bib18","first-page":"298","article-title":"Arboviruses: case studies of transmission: Rift Valley fever virus","volume":"vol. 3","author":"Clements","year":"2012"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3201\/eid0402.980218","article-title":"New vectors of Rift Valley fever in West Africa","volume":"4","author":"Fontenille","year":"1998","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.cll.2017.01.004_bib20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/0035-9203(80)90213-8","article-title":"Possible vectors of Rift Valley fever in Kenya","volume":"74","author":"Davies","year":"1980","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"24","key":"10.1016\/j.cll.2017.01.004_bib21","first-page":"867","article-title":"Rift Valley fever affecting humans in South Africa: a clinicopathological study","volume":"51","author":"van Velden","year":"1977","journal-title":"S\u00a0Afr Med J"},{"issue":"1","key":"10.1016\/j.cll.2017.01.004_bib22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1017\/S0022172400062434","article-title":"Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya","volume":"95","author":"Linthicum","year":"1985","journal-title":"J\u00a0Hyg (Lond)"},{"issue":"5","key":"10.1016\/j.cll.2017.01.004_bib23","first-page":"941","article-title":"Rainfall and epizootic Rift Valley fever","volume":"63","author":"Davies","year":"1985","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.cll.2017.01.004_bib24","first-page":"62","article-title":"Isolation of Rift Valley fever virus from bats in the Republic of Guinea","volume":"80","author":"Boiro","year":"1987","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"1","key":"10.1016\/j.cll.2017.01.004_bib25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3201\/eid2201.150725","article-title":"Rift Valley fever virus among wild ruminants, Etosha National Park, Namibia, 2011","volume":"22","author":"Capobianco Dondona","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1017\/S0022172400061441","article-title":"Rift Valley fever in Kenya: the presence of antibody to the virus in camels (Camelus dromedarius)","volume":"94","author":"Davies","year":"1985","journal-title":"J\u00a0Hyg (Lond)"},{"issue":"4","key":"10.1016\/j.cll.2017.01.004_bib27","first-page":"391","article-title":"Rift Valley fever. 1. Vector studies in the field","volume":"43","author":"McIntosh","year":"1972","journal-title":"J\u00a0S Afr Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.cll.2017.01.004_bib28","doi-asserted-by":"publisher","first-page":"e0003548","DOI":"10.1371\/journal.pntd.0003548","article-title":"Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya","volume":"9","author":"LaBeaud","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"2 Suppl","key":"10.1016\/j.cll.2017.01.004_bib29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4269\/ajtmh.2010.09-0293","article-title":"Risk factors for severe Rift Valley fever infection in Kenya, 2007","volume":"83","author":"Anyangu","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.cll.2017.01.004_bib30","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"49","key":"10.1016\/j.cll.2017.01.004_bib31","first-page":"908","article-title":"Rift Valley fever in South Africa. 2. The occurrence of human cases in the Orange Free State, the North-Western Cape Province, the Western and Southern Transvaal. B. Field and laboratory investigation","volume":"25","author":"Gear","year":"1951","journal-title":"S\u00a0Afr Med J"},{"issue":"20","key":"10.1016\/j.cll.2017.01.004_bib32","first-page":"803","article-title":"Rift Valley fever in humans in South Africa","volume":"58","author":"McIntosh","year":"1980","journal-title":"S\u00a0Afr Med J"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3201\/eid1902.120941","article-title":"Rift Valley fever and a new paradigm of research and development for zoonotic disease control","volume":"19","author":"Dar","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cll.2017.01.004_bib34","unstructured":"ProMed-mail. Rift Valley fever - Uganda (Kabale). 2016. 20160313.4090478. Available at: http:\/\/www.promedmail.org. Accessed September 2, 2016."},{"key":"10.1016\/j.cll.2017.01.004_bib35","unstructured":"Lam Ayebe A. Uganda: Govt Confirms Rift Valley Fever Outbreak. 2016. Available at: http:\/\/allafrica.com\/stories\/201603220149.html. Accessed August 24, 2016."},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1017\/S0950268800068011","article-title":"Rift Valley fever: a sero-epidemiological survey among pregnant women in Mozambique","volume":"99","author":"Niklasson","year":"1987","journal-title":"Epidemiol Infect"},{"issue":"5","key":"10.1016\/j.cll.2017.01.004_bib37","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/jmv.21132","article-title":"Case report: Rift Valley fever with vertical transmission in a pregnant Sudanese woman","volume":"80","author":"Adam","year":"2008","journal-title":"J\u00a0Med Virol"},{"issue":"3","key":"10.1016\/j.cll.2017.01.004_bib38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1179\/146532806X120363","article-title":"Vertical transmission of fatal Rift Valley fever in a newborn","volume":"26","author":"Arishi","year":"2006","journal-title":"Ann Trop Paediatr"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4049\/jimmunol.62.2.213","article-title":"Rift Valley fever; accidental infections among laboratory workers","volume":"62","author":"Smithburn","year":"1949","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.cll.2017.01.004_bib40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1084\/jem.62.3.433","article-title":"Rift Valley fever: a report of three cases of laboratory infection and the experimental transmission of the disease to ferrets","volume":"62","author":"Francis","year":"1935","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cll.2017.01.004_bib41","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4269\/ajtmh.1934.s1-14.547","article-title":"Laboratory infections with the virus of Rift Valley fever","volume":"14","author":"Kitchen","year":"1934","journal-title":"Am J Trop Med"},{"issue":"3","key":"10.1016\/j.cll.2017.01.004_bib42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1084\/jem.59.3.305","article-title":"Rift Valley fever in man: report of a fatal laboratory infection complicated by thrombophlebitis","volume":"59","author":"Schwentker","year":"1934","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.cll.2017.01.004_bib43","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3181\/00379727-64-15803","article-title":"Human infection with Rift Valley fever virus and immunity twelve years after single attack","volume":"64","author":"Sabin","year":"1947","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.cll.2017.01.004_bib44","unstructured":"James Martin Center for Nonproliferation Studies. Chemical and biological weapons: possession and programs past and present. 2008. Available at: http:\/\/cns.miis.edu\/cbw\/possess.htm. Accessed July 9, 2015."},{"key":"10.1016\/j.cll.2017.01.004_bib45","series-title":"The soviet biological weapons program: a history","author":"Leitenberg","year":"2012"},{"key":"10.1016\/j.cll.2017.01.004_bib46","series-title":"Deadly cultures: biological weapons since 1945","first-page":"9","article-title":"The US Biological Weapons Program","author":"Ellis","year":"2006"},{"key":"10.1016\/j.cll.2017.01.004_bib47","series-title":"Deadly cultures: biological weapons since 1945","first-page":"84","article-title":"The Canadian Biological Weapons Program and the tripartite alliance","author":"Avery","year":"2006"},{"key":"10.1016\/j.cll.2017.01.004_bib48","volume":"vol. 1","author":"International Institute for Peace and Conflict Research","year":"1971"},{"key":"10.1016\/j.cll.2017.01.004_bib49","series-title":"Factories of death: Japanese biological warfare, 1932-45, and the American cover-up","author":"Harris","year":"1994"},{"key":"10.1016\/j.cll.2017.01.004_bib50","series-title":"Deadly allies: Canada's secret war 1937-1947","author":"Bryden","year":"1989"},{"key":"10.1016\/j.cll.2017.01.004_bib51","series-title":"Deadly cultures: biological weapons since 1945","first-page":"224","article-title":"Antianimal biological weapons programs","author":"Millet","year":"2006"},{"key":"10.1016\/j.cll.2017.01.004_bib52","series-title":"The United States and Biological Warfare: secrets from the early cold war and Korea","author":"Endicott","year":"1998"},{"key":"10.1016\/j.cll.2017.01.004_bib53","unstructured":"Jones K. A brief history of the U.S. Army Project Fort Detrick Operation Whitecoat. Available at: http:\/\/usarmywhitecoat.com\/?page_id=7. Accessed August 24, 2016."},{"key":"10.1016\/j.cll.2017.01.004_bib54","unstructured":"Anderson AO. Infectious Disease and the Ethics of Human Volunteers in respect to the Whitecoat Project. Available at: http:\/\/usarmywhitecoat.com\/wp-content\/uploads\/2013\/12\/1954-73-Op-Whitecoat-ID-Res-No-Video-press.pdf. Accessed August 25, 2015."},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib55","first-page":"108","article-title":"Rift Valley fever virus: a real bioterror threat","volume":"2","author":"Mandell","year":"2011","journal-title":"Bioterror Biodefense."},{"key":"10.1016\/j.cll.2017.01.004_bib56","series-title":"Biosafety in microbiological and biomedical laboratories","author":"US Department of Health and Human Services","year":"2009"},{"issue":"1","key":"10.1016\/j.cll.2017.01.004_bib57","first-page":"11","article-title":"The pathology of Rift Valley fever. II. Lesions occurring in field cases in adult cattle, calves and aborted foetuses","volume":"49","author":"Coetzer","year":"1982","journal-title":"Onderstepoort J Vet Res"},{"issue":"4","key":"10.1016\/j.cll.2017.01.004_bib58","first-page":"205","article-title":"The pathology of Rift Valley fever. I. Lesions occurring in natural cases in new-born lambs","volume":"44","author":"Coetzer","year":"1977","journal-title":"Onderstepoort J Vet Res"},{"issue":"4","key":"10.1016\/j.cll.2017.01.004_bib59","first-page":"341","article-title":"Distribution of viral antigen in tissues of new-born lambs infected with Rift Valley fever virus","volume":"63","author":"Van der Lugt","year":"1996","journal-title":"Onderstepoort J Vet Res"},{"issue":"6","key":"10.1016\/j.cll.2017.01.004_bib60","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/0035-9203(79)90006-3","article-title":"Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness","volume":"73","author":"Laughlin","year":"1979","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"50","key":"10.1016\/j.cll.2017.01.004_bib61","first-page":"930","article-title":"Rift valley fever in man, complicated by retinal changes and loss of vision","volume":"25","author":"Freed","year":"1951","journal-title":"S\u00a0Afr Med J"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ophtha.2004.09.018","article-title":"Ocular complications of Rift Valley fever outbreak in Saudi Arabia","volume":"112","author":"Al-Hazmi","year":"2005","journal-title":"Ophthalmology"},{"issue":"8880","key":"10.1016\/j.cll.2017.01.004_bib63","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/0140-6736(93)92128-G","article-title":"Recurrence of Rift Valley fever in Egypt","volume":"342","author":"Arthur","year":"1993","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cll.2017.01.004_bib64","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/bjo.64.5.366","article-title":"Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt","volume":"64","author":"Siam","year":"1980","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.cll.2017.01.004_bib65","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/0035-9203(78)90134-7","article-title":"Rift Valley fever virus infections in Egypt: pathological and virological findings in man","volume":"72","author":"Abdel-Wahab","year":"1978","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.cll.2017.01.004_bib66","doi-asserted-by":"publisher","first-page":"e0003584","DOI":"10.1371\/journal.pntd.0003584","article-title":"Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways","volume":"9","author":"Hise","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"2 Suppl","key":"10.1016\/j.cll.2017.01.004_bib67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4269\/ajtmh.2010.09-0318","article-title":"Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007","volume":"83","author":"Mohamed","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"18","key":"10.1016\/j.cll.2017.01.004_bib68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2807\/1560-7917.ES.2016.21.18.30222","article-title":"Rift Valley fever in kidney transplant recipient returning from Mali with viral RNA detected in semen up to four months from symptom onset, France, autumn 2015","volume":"21","author":"Haneche","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cll.2017.01.004_bib69","unstructured":"World Organization for Animal Health (OIE). List of Reference Experts and Laboratories. Available at: http:\/\/www.oie.int\/en\/our-scientific-expertise\/reference-laboratories\/list-of-laboratories\/. Accessed September 19, 2016."},{"issue":"S4","key":"10.1016\/j.cll.2017.01.004_bib70","doi-asserted-by":"publisher","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2017.01.004_bib71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.cll.2017.01.004_bib72","first-page":"718","article-title":"A\u00a0nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part II. Management of patients","volume":"68","author":"van Eeden","year":"1985","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.cll.2017.01.004_bib73","series-title":"Hunter's tropical medicine and emerging infectious disease","first-page":"340","article-title":"Rift Valley fever","author":"Bird","year":"2012"},{"issue":"4","key":"10.1016\/j.cll.2017.01.004_bib74","doi-asserted-by":"publisher","first-page":"e2790","DOI":"10.1371\/journal.pntd.0002790","article-title":"Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever","volume":"8","author":"Caroline","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.cll.2017.01.004_bib75","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.coviro.2012.02.017","article-title":"Breaking the chain: Rift Valley fever virus control via livestock vaccination","volume":"2","author":"Bird","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.cll.2017.01.004_bib76","series-title":"Protecting the frontline in biodefense research: the special immunizations program","author":"Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Select Agents","year":"2011"},{"key":"10.1016\/j.cll.2017.01.004_bib77","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4049\/jimmunol.93.2.293","article-title":"Immunization against Rift Valley fever virus. Studies on the immunogenicity of lyophilized formalin-inactivated vaccine","volume":"93","author":"Randall","year":"1964","journal-title":"J\u00a0Immunol"},{"issue":"5","key":"10.1016\/j.cll.2017.01.004_bib78","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/oxfordjournals.aje.a113471","article-title":"A\u00a0Rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up","volume":"116","author":"Kark","year":"1982","journal-title":"Am J Epidemiol"},{"issue":"17","key":"10.1016\/j.cll.2017.01.004_bib79","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1016\/j.vaccine.2011.02.037","article-title":"Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study","volume":"29","author":"Rusnak","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.cll.2017.01.004_bib80","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill","year":"1987","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.cll.2017.01.004_bib81","doi-asserted-by":"publisher","first-page":"e0004550","DOI":"10.1371\/journal.pntd.0004550","article-title":"Rift Valley fever vaccine virus clone 13 is able to cross the ovine placental barrier associated with foetal infections, malformations, and stillbirths","volume":"10","author":"Makoschey","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.cll.2017.01.004_bib82","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","article-title":"Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"issue":"10","key":"10.1016\/j.cll.2017.01.004_bib83","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.cll.2017.01.004_bib84","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.vaccine.2012.10.118","article-title":"Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.cll.2017.01.004_bib85","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/1743-422X-8-532","article-title":"Observations on rift valley fever virus and vaccines in Egypt","volume":"8","author":"Ahmed Kamal","year":"2011","journal-title":"Virol J"},{"issue":"4","key":"10.1016\/j.cll.2017.01.004_bib86","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.vaccine.2015.12.030","article-title":"Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans","volume":"34","author":"Pittman","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.cll.2017.01.004_bib87","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.vaccine.2015.11.078","article-title":"Rift Valley fever MP-12 vaccine phase 2 clinical trial: safety, immunogenicity, and genetic characterization of virus isolates","volume":"34","author":"Pittman","year":"2016","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.cll.2017.01.004_bib88","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"Pittman","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.cll.2017.01.004_bib89","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"Bird","year":"2008","journal-title":"J\u00a0Virol"},{"issue":"24","key":"10.1016\/j.cll.2017.01.004_bib90","doi-asserted-by":"publisher","first-page":"12901","DOI":"10.1128\/JVI.06046-11","article-title":"Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep","volume":"85","author":"Bird","year":"2011","journal-title":"J\u00a0Virol"},{"issue":"43","key":"10.1016\/j.cll.2017.01.004_bib91","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1016\/j.vaccine.2013.08.003","article-title":"Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.cll.2017.01.004_bib92","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.antiviral.2014.03.008","article-title":"One health approach to Rift Valley fever vaccine development","volume":"106","author":"Kortekaas","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.cll.2017.01.004_bib93","doi-asserted-by":"publisher","first-page":"20617","DOI":"10.1038\/srep20617","article-title":"Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever","volume":"6","author":"Warimwe","year":"2016","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.cll.2017.01.004_bib94","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.vaccine.2016.03.061","article-title":"Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle","volume":"34","author":"Dulal","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.cll.2017.01.004_bib95","doi-asserted-by":"publisher","first-page":"e0003550","DOI":"10.1371\/journal.pntd.0003550","article-title":"Randomized controlled field trial to assess the immunogenicity and safety of Rift Valley fever clone 13 vaccine in livestock","volume":"9","author":"Njenga","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.cll.2017.01.004_bib96","first-page":"31","article-title":"Recognizing Rift Valley fever","volume":"42","author":"Davies","year":"2006","journal-title":"Vet Ital"},{"issue":"12","key":"10.1016\/j.cll.2017.01.004_bib97","doi-asserted-by":"publisher","first-page":"e0004314","DOI":"10.1371\/journal.pntd.0004314","article-title":"The risk of nosocomial transmission of Rift Valley fever","volume":"9","author":"Al-Hamdan","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cll.2017.01.004_bib98","unstructured":"ProMed-mail. Rift Valley fever - China (02): ex Angola, comment. 2016. 20160727.4371805. Available at: http:\/\/www.promedmail.org. Accessed September 2, 2016."},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib99","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11250-010-9719-7","article-title":"Risk assessment of the introduction of Rift Valley fever from the Horn of Africa to Yemen via legal trade of small ruminants","volume":"43","author":"Abdo-Salem","year":"2011","journal-title":"Trop Anim Health Prod"},{"issue":"12","key":"10.1016\/j.cll.2017.01.004_bib100","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3201\/eid0812.020195","article-title":"Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01","volume":"8","author":"Shoemaker","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cll.2017.01.004_bib101","unstructured":"ProMed-mail. Rift Valley fever - China: ex Angola. 2016. 20160725.4368585. Available at: http:\/\/www.promedmail.org. Accessed September 2, 2016."},{"key":"10.1016\/j.cll.2017.01.004_bib102","unstructured":"ProMed-mail. Rift Valley fever, human - France: ex Zimbabwe (Mashonaland East) first report. 2011. 20111020.3132. Available at: http:\/\/www.promedmail.org. Accessed September 2, 2016."},{"key":"10.1016\/j.cll.2017.01.004_bib103","unstructured":"ProMed-mail. Rift Valley fever - France ex Mali, 2015. 2016. 20160506.4207036. Available at: http:\/\/www.promedmail.org. Accessed September 2, 2016."},{"issue":"12","key":"10.1016\/j.cll.2017.01.004_bib104","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1038\/emi.2013.81","article-title":"The risk of Rift Valley fever virus introduction and establishment in the United States and European Union","volume":"2","author":"Rolin","year":"2013","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"10.1016\/j.cll.2017.01.004_bib105","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1603\/ME13049","article-title":"Potential for mosquitoes (Diptera: Culicidae) from Florida to transmit Rift valley fever virus","volume":"50","author":"Turell","year":"2013","journal-title":"J\u00a0Med Entomol"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib106","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2987\/12-6316r.1","article-title":"Potential for populations of Aedes J. Japonicus to transmit rift valley fever virus in the USA","volume":"29","author":"Turell","year":"2013","journal-title":"J\u00a0Am Mosq Control Assoc"},{"issue":"11","key":"10.1016\/j.cll.2017.01.004_bib107","doi-asserted-by":"publisher","first-page":"e2515","DOI":"10.1371\/journal.pntd.0002515","article-title":"Data-driven modeling to assess receptivity for rift valley Fever virus","volume":"7","author":"Barker","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cll.2017.01.004_bib108","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fmicb.2015.00664","article-title":"Comparison of Rift Valley fever virus replication in North American livestock and wildlife cell lines","volume":"6","author":"Gaudreault","year":"2015","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib109","first-page":"167","article-title":"Rift Valley fever. 3. Viraemia in cattle and sheep. 4. The susceptibility of mice and hamsters in relation to transmission of virus by mosquitoes","volume":"44","author":"McIntosh","year":"1973","journal-title":"J\u00a0S Afr Vet Assoc"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib110","first-page":"103","article-title":"Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus. I. Macroscopic and microscopic pathology","volume":"49","author":"Coetzer","year":"1982","journal-title":"Onderstepoort J Vet Res"},{"issue":"2","key":"10.1016\/j.cll.2017.01.004_bib111","first-page":"109","article-title":"Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus. II. Ultrastructural findings","volume":"49","author":"Coetzer","year":"1982","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.cll.2017.01.004_bib112","unstructured":"Food and Agriculture Organization of the United Nations. Emergency preparedness planning: Rift Valley fever. Available at: http:\/\/www.fao.org\/ag\/againfo\/resources\/documents\/AH\/RVF198.htm. Accessed August 24, 2016."}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271217300069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271217300069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T15:48:03Z","timestamp":1750175283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271217300069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0272271217300069"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2017.01.004","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rift Valley Fever","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}